Other Tracked since Q3 FY26 - Q3 FY26

Gufic Biosciences Limited

GUFICBIOSCIENCES

Latest quarter Q3 FY26

Revenue ₹231 Cr

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal neutral

Gufic Biosciences reported Q3 FY26 revenue of ₹231.1 crore, flat sequentially, as a conscious ₹14-16 crore revenue hi...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 10 Feb 2026

neutral medium

Revenue ₹231 Cr

Gufic Biosciences reported Q3 FY26 revenue of ₹231.1 crore, flat sequentially, as a conscious ₹14-16 crore revenue hit from restructuring critical care and SPARSH dist...

Scorecard starts after historical backfill Read full analysis →